BCM
AXGN icon

Bayesian Capital Management’s Axogen AXGN Stock Holding History

Bayesian Capital Management’s Portfolio AXGN Stock Details AXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-7,800
Closed -$285K – 592
2018
Q1 		$285K Buy
+7,800
New +$239K 0.07% 408

Other funds holding AXGN

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bayesian Capital Management's AXGN Position: Q2 2018 in Review

Bayesian Capital Management sold out of Axogen (AXGN) in Q2 2018, closing a stake of 7,800 shares — an estimated $285K sold.

Bayesian Capital Management first reported a position in AXGN in Q1 2018 and held it in 1 quarter. The position peaked at $285K in Q1 2018. 177 funds tracked by Wall St. Rank hold AXGN as of Q2 2018.

  • Bayesian Capital Management reported no remaining Axogen position as of Q2 2018 after selling out during the quarter.
  • Bayesian Capital Management sold 7,800 Axogen shares in Q2 2018, an estimated $285K.
  • Bayesian Capital Management first reported a position in Axogen in Q1 2018 and held it in 1 quarter.
  • Bayesian Capital Management's Axogen position peaked at $285K in Q1 2018.
  • 177 funds tracked by Wall St. Rank held Axogen as of Q2 2018.

Based on Bayesian Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.